V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008102 | 280005334 | null | 71.4 | Palliative (P) | 2014-02-26 | 2014-02-27 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026275 | RMS 2005 TRIAL |
| 280008103 | 280008808 | 1.62 | 60.3 | Curative (C) | 2016-12-17 | 2017-01-14 | CETUXIMAB + RT | N | N | 280026277 | CETUXIMAB + RT |
| 280008104 | 280010482 | 0 | 55 | Curative (C) | 2013-05-17 | 2013-12-26 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026279 | RMS 2005 TRIAL |
| 280008105 | 280010482 | 1.76 | 67.2 | Curative (C) | 2017-07-21 | 2017-08-15 | Ifosfamide | 02 | N | 280026279 | IFOSFAMIDE |
| 280008106 | 280005336 | 1.65 | 62.6 | Not known (9) | 2014-11-17 | 2014-12-13 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026282 | PACLITAXEL |
| 280008107 | 280005337 | 1.77 | 92.8 | Palliative (P) | 2017-09-15 | 2017-09-23 | Doxorubicin 75mg/m2 | N | N | 280026282 | DOXORUBICIN |
| 280008108 | 280005338 | 1.88 | 72.7 | Curative (C) | null | 2016-01-29 | CETUXIMAB + RT | N | Y | 280026291 | CETUXIMAB + RT |
| 280008109 | 280005338 | 1.74 | 61.9 | Palliative (P) | 2017-07-31 | 2017-08-07 | PACLITAXEL | null | null | 280026291 | PACLITAXEL |
| 280008110 | 280008811 | 1.56 | 50.1 | Neo-adjuvant (N) | 2012-09-06 | 2013-11-18 | Ifosfamide | N | null | 280026292 | IFOSFAMIDE |
| 280008111 | 280011302 | 1.62 | 79 | Neo-adjuvant (N) | null | 2014-10-28 | Cetuximab + Radiotherapy Maint | 2 | N | 280026301 | CETUXIMAB + RT |
| 280008112 | 280005342 | 1.73 | 96.5 | Curative (C) | 2016-06-30 | 2016-07-02 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026311 | RMS 2005 TRIAL |
| 280008113 | 280005343 | 1.63 | 48.1 | Palliative (P) | null | 2017-09-05 | Ifosfamide PVI 1g/m2 14day | N | N | 280026313 | IFOSFAMIDE |
| 280008114 | 280005348 | 1.82 | 81 | Palliative (P) | 2017-05-10 | 2017-05-10 | Paclitaxel 7 day | 02 | N | 280026314 | PACLITAXEL |
| 280008115 | 280008815 | 0 | 81.6 | Curative (C) | 2015-07-12 | 2016-02-02 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 280026319 | RMS 2005 TRIAL |
| 280008116 | 280005351 | 157 | 52.5 | Palliative (P) | 2013-08-28 | 2013-09-15 | Doxorubicin 75mg/m2 | N | N | 280026325 | DOXORUBICIN |
| 280008117 | 280008816 | 1.82 | 75 | null | 2016-05-31 | 2016-06-27 | CETUXIMAB + RT | N | N | 280026327 | CETUXIMAB + RT |
| 280008118 | 280005352 | 1.77 | null | Neo-adjuvant (N) | 2015-06-26 | 2015-07-10 | CETUXIMAB + RT | N | N | 280026329 | CETUXIMAB + RT |
| 280008119 | 280008817 | 1.59 | null | Palliative (P) | 2014-10-15 | 2014-10-16 | DOXORUBICIN | 02 | null | 280026333 | DOXORUBICIN |
| 280008120 | 280005353 | null | 87 | Curative (C) | 2015-08-07 | 2015-06-30 | CARBOPLATIN + RT | N | Y | 280026334 | CARBOPLATIN + RT |
| 280008121 | 280005354 | 0 | null | Neo-adjuvant (N) | 2017-08-26 | 2017-08-26 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026342 | RMS 2005 TRIAL |
| 280008122 | 280008818 | 0 | 72.6 | null | null | 2017-10-03 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026344 | IVA |
| 280008123 | 280005357 | 1.82 | 73.7 | Curative (C) | 2018-07-03 | 2018-07-03 | Ifosfamide | N | N | 280026347 | IFOSFAMIDE |
| 280008124 | 280005359 | 1.72 | 90 | Palliative (P) | 2016-11-05 | 2016-11-19 | DOXORUBICIN | 2 | N | 280026348 | DOXORUBICIN |
| 280008125 | 280005360 | null | 64 | Palliative (P) | 2017-02-07 | 2017-02-07 | DOXORUBICIN | 02 | N | 280026350 | DOXORUBICIN |
| 280008126 | 280008819 | 0 | null | Disease modification (D) | 2018-03-21 | 2018-06-04 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026352 | RMS 2005 TRIAL |
| 280008127 | 280005362 | 1.8 | 74.6 | Adjuvant (A) | null | 2014-10-21 | Cetuximab + Radiotherapy Maint | N | N | 280026361 | CETUXIMAB + RT |
| 280008128 | 280010488 | null | 0 | Curative (C) | 2015-09-06 | 2015-09-16 | CARBOPLATIN + RT | 02 | null | 280026363 | CARBOPLATIN + RT |
| 280008129 | 280005363 | 1.71 | null | null | 2013-07-11 | 2013-07-25 | Cetuximab + Radiotherapy Maint | 02 | null | 280026365 | CETUXIMAB + RT |
| 280008130 | 280005363 | 1.36 | 58 | Curative (C) | 2015-01-17 | 2015-03-10 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026365 | IVA |
| 280008131 | 280005364 | 1.7 | 59 | Curative (C) | 2013-08-11 | 2013-09-01 | Cetuximab + Radiotherapy Maint | N | Y | 280026376 | CETUXIMAB + RT |
| 280008132 | 280008822 | 1.71 | 90.4 | Curative (C) | 2014-02-03 | 2014-02-24 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280026385 | RMS 2005 TRIAL |
| 280008133 | 280008823 | 1.67 | null | Palliative (P) | 2014-03-30 | 2014-04-14 | DOXORUBICIN | 02 | null | 280026386 | DOXORUBICIN |
| 280008134 | 280005367 | 1.74 | 71 | Palliative (P) | 2016-03-08 | 2016-03-08 | Paclitaxel 7 day | 02 | N | 280026392 | PACLITAXEL |
| 280008135 | 280005369 | 1.78 | null | Palliative (P) | 2018-04-20 | 2018-04-20 | Paclitaxel 7 day | N | N | 280026396 | PACLITAXEL |
| 280008136 | 280005370 | 1.49 | 48.1 | Palliative (P) | 2015-10-22 | 2015-10-22 | Paclitaxel 7 day | 2 | N | 280026402 | PACLITAXEL |
| 280008137 | 280005372 | 1.75 | 68.7 | Neo-adjuvant (N) | 2013-12-19 | 2013-12-25 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280026402 | PACLITAXEL |
| 280008138 | 280005373 | 1.75 | null | Adjuvant (A) | 2016-08-21 | 2016-10-05 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026417 | IVA |
| 280008139 | 280010491 | 1.63 | 89 | null | 2003-04-11 | 2017-09-20 | Cetuximab + Radiotherapy Load | null | Y | 280026419 | CETUXIMAB + RT |
| 280008140 | 280011702 | 1.74 | null | Neo-adjuvant (N) | 2015-06-07 | 2015-06-07 | PACLITAXEL | 01 | N | 280026426 | PACLITAXEL |
| 280008141 | 280011702 | 1.7 | null | Curative (C) | 2018-05-30 | 2018-06-01 | Ifosfamide PVI 1g/m2 14day | N | Y | 280026426 | IFOSFAMIDE |
| 280008142 | 280011702 | null | 72 | Neo-adjuvant (N) | null | 2017-07-12 | DOXORUBICIN | 02 | N | 280026426 | DOXORUBICIN |
| 280008143 | 280011702 | null | 70.8 | Curative (C) | 2016-07-20 | 2016-09-01 | IVA | N | N | 280026426 | IVA |
| 280008144 | 280005374 | 1.7 | 15.9 | Palliative (P) | 2017-10-12 | 2017-11-02 | Ifosfamide | Y | N | 280026440 | IFOSFAMIDE |
| 280008145 | 280005375 | 1.54 | 116 | Adjuvant (A) | 2015-05-12 | 2015-07-12 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026444 | IVA |
| 280008146 | 280008828 | 1.81 | 64.5 | Neo-adjuvant (N) | null | 2014-11-08 | Cetuximab + Radiotherapy Maint | 2 | Y | 280026458 | CETUXIMAB + RT |
| 280008147 | 280010492 | null | null | Neo-adjuvant (N) | 2015-12-18 | 2016-01-02 | DOXORUBICIN | N | null | 280026462 | DOXORUBICIN |
| 280008148 | 280008829 | null | 70.9 | null | null | 2014-07-11 | Cisplatin 7 day | 2 | N | 280026469 | CISPLATIN |
| 280008149 | 280005377 | 0 | null | Disease modification (D) | 2013-03-21 | 2013-05-30 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | 280026471 | RMS 2005 TRIAL |
| 280008150 | 280005378 | 1.77 | 31 | Curative (C) | 2014-09-02 | 2014-11-17 | Cisplatin | null | null | 280026472 | CISPLATIN |
| 280008151 | 280008830 | 1.71 | 60.9 | Curative (C) | 2016-11-06 | 2017-02-17 | Ifosfamide | 02 | N | 280026477 | IFOSFAMIDE |